CITR CitroTech Inc.
Chemicals & Allied Products · NYSE · SEC CIK 894556 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-14.3%
TTM net income YoY43.2%
TTM EPS YoY78.7%
Revenue 3-yr CAGR87.7%
Net income 3-yr CAGR—
Margins
Gross margin23.6%
Operating margin-927.5%
Net margin-1,071.4%
FCF margin-447.2%
EBITDA margin-901.0%
Returns
ROE-235.3%
ROA-177.7%
ROIC (approx.)-293.9%
Asset turnover0.17x
Leverage & solvency
Liabilities / assets15.7%
Debt / equity0.00x
Current ratio2.99x
Interest coverage-44.68x
Cash quality & payout
Operating cash flow / net income0.42x
Accruals ratio-103.5%
Payout ratio—
Capex / revenue-0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $664,328 | $280,666 | $344,915 | $436,175 | $288,212 | $687,638 | $969,382 | $69,643 |
| Cost of revenue | $474,535 | $271,628 | $225,577 | $346,717 | $575,603 | $371,392 | $617,260 | $215,937 |
| Gross profit | $189,793 | $9,038 | $119,338 | $89,458 | -$287,391 | $316,246 | $352,122 | -$146,294 |
| R&D expense | $145,919 | $197,067 | $81,525 | $69,497 | $79,700 | $41,276 | $8,031 | — |
| SG&A expense | $278,894 | $218,290 | $409,956 | $721,531 | $269,703 | $270,227 | $203,171 | -$35,863 |
| Operating income | -$2.29M | -$3.49M | -$4.45M | -$5.78M | -$4.24M | -$3.02M | -$3.46M | -$1.20M |
| Interest expense | $2,131 | $3,569 | $164,833 | $187,797 | $360,236 | $552,085 | $410,791 | $163,022 |
| Pretax income | -$2.28M | -$3.90M | -$6.21M | -$6.10M | -$7.93M | -$11.90M | -$10.90M | -$1.80M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$2.28M | -$3.90M | -$6.21M | -$6.10M | -$7.93M | -$11.90M | -$10.90M | -$1.80M |
| EBITDA | -$2.17M | -$3.37M | -$4.32M | -$5.69M | -$4.15M | -$2.94M | -$3.38M | -$1.12M |
| EPS (basic) | -0.10 | -0.18 | -0.33 | — | -0.59 | -1.14 | -1.37 | — |
| EPS (diluted) | -0.10 | -0.18 | -0.33 | — | -0.59 | -1.14 | -1.37 | — |
| Weighted avg. shares (diluted) | 22.18M | 21.75M | 18.83M | — | 13.52M | 10.46M | 7.98M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $1.09M | $2.52M | $4.29M | $6.27M | $6.20M | $2.33M | $3.74M | $775,133 |
| Receivables | $263,751 | $165,436 | $130,314 | $209,047 | $508,175 | $653,995 | $745,769 | $317,455 |
| Inventory | $542,280 | $579,125 | $696,142 | $620,768 | $467,317 | $409,923 | $312,484 | $324,657 |
| Current assets | $2.34M | $3.68M | $5.63M | $7.42M | $7.26M | $3.78M | $5.01M | $1.62M |
| PP&E, net | $469,495 | $484,050 | $610,787 | $630,279 | $664,118 | $465,511 | $339,879 | $111,374 |
| Intangibles | $5.04M | $5.14M | $5.23M | $5.33M | $3.51M | $3.58M | $3.64M | $3.70M |
| Total assets | $8.55M | $10.04M | $12.24M | $14.18M | $12.26M | $8.69M | $9.05M | $5.48M |
| Current liabilities | $782,922 | $420,088 | $2.85M | $2.17M | $2.97M | $5.80M | $4.96M | $2.16M |
| Short-term debt | — | — | — | — | $47,603 | $0 | $0 | $96,849 |
| Long-term debt | — | — | — | — | $125,149 | — | — | $0 |
| Total debt | — | — | — | — | $172,752 | — | — | $96,849 |
| Total liabilities | $1.34M | $1.02M | $3.56M | $2.92M | $3.75M | $6.50M | $4.96M | $2.16M |
| Shareholders' equity | $7.21M | $9.01M | $8.69M | $11.26M | $8.51M | $2.19M | $4.09M | $3.32M |
| Net debt | — | — | — | — | -$6.02M | — | — | -$678,284 |
| Shares outstanding | 22.72M | 22.51M | 19.12M | 18.52M | 17.55M | 66.09M | 52.38M | 6.14M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.40M | -$1.78M | -$2.06M | -$2.48M | -$1.46M | -$1.21M | -$713,918 | -$617,836 |
| Capital expenditure | $10,800 | $0 | $10,727 | -$27,717 | $53,926 | $140,756 | $26,988 | $0 |
| Free cash flow | -$1.41M | -$1.78M | -$2.07M | -$2.45M | -$1.51M | -$1.35M | -$740,906 | -$617,836 |
| Investing cash flow | -$10,800 | $12,500 | -$10,727 | -$72,283 | -$53,926 | -$140,756 | -$26,988 | $0 |
| Financing cash flow | -$19,136 | $3,292 | $88,374 | $2.63M | $5.38M | -$60,875 | $3.71M | $1.08M |
| Depreciation & amortization | $120,820 | $123,850 | $125,684 | $87,634 | $90,054 | $77,107 | $74,539 | $74,449 |
| Stock-based compensation | $475,487 | $1.95M | $2.28M | $12.36M | $2.12M | $4.40M | $8.94M | $499,999 |
Free plan shows the latest 8 periods; Pro shows all 27 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.